Infectious Complications in Bariatric Surgery

Author(s):  
Jacques Choucair
2009 ◽  
Vol 19 (7) ◽  
pp. 867-872 ◽  
Author(s):  
Wilson Salgado ◽  
Fernando de Queiroz Cunha ◽  
José Sebastião dos Santos ◽  
Carla Barbosa Nonino-Borges ◽  
Ajith Kumar Sankarankutty ◽  
...  

2018 ◽  
Vol 46 (7) ◽  
pp. 2696-2707 ◽  
Author(s):  
Tadeja Pintar ◽  
Niko Kaliterna ◽  
Tanja Carli

Objective High-quality data indicating the advantages of preoperative Helicobacter pylori screening and eradication as well the clinical outcomes of patients with and without H. pylori after bariatric surgery are lacking. Methods In total, 96 morbidly obese patients with H. pylori preparing for bariatric surgery were retrospectively reviewed. Results Of 96 biopsy specimens, 73 (76%) were positive for H. pylori on initial Giemsa staining. These patients were treated with the standard 7-day antibiotic treatment protocol corrected by the individual patient’s creatinine clearance rate and body mass index and received a 30% higher dose because of their H. pylori positivity. A linear correlation was found between the effective antibiotic dose and the BMI with a recurrence rate of only 2.1% (2/96 patients). The preoperative percent estimated weight loss before surgery (17%) and in the first year of follow-up (68%–88%) was statistically equal between H. pylori-positive and -negative patients. Two early postoperative infectious complications and two postoperative surgical complications occurred in the preoperatively H. pylori-positive patients. Conclusions A patient-tailored H. pylori eradication protocol prior to bariatric surgery is mandatory to improve the eradication rate and reduce the incidence of postoperative complications in mostly asymptomatic H. pylori-positive bariatric candidates.


Author(s):  
Mohammad Alsulaimy ◽  
Seyed Mohammad Kalantar Motamedi

Morbid obesity is associated with an increased risk of infectious complications including surgical site, urinary tract, and pulmonary infections. Surgical site infections (SSI) are the most common, followed by urinary and respiratory infections. Various risk factors in obese patients including impaired immunity, and altered pulmonary and circulatory systems contribute to the increased susceptibility of morbid obese patients to infectious complications. Perioperative infections are defined to occur within 30 days of the initial operative procedure. Surgical site and urinary tract infections usually occur within 7–10 days post-operatively. Therefore, it is recommended that patients should be followed up between 7 to 10 days post-op to examine surgical sites, and to screen for possible urinary tract symptoms. This chapter will discuss the diagnosis, treatment, and possible preventative measures of the aforementioned infectious complications in the bariatric surgery population.


2006 ◽  
Vol 175 (4S) ◽  
pp. 493-494
Author(s):  
Jared M. Whitson ◽  
G. Bennett Stackhouse ◽  
Marshall L. Stoller

Sign in / Sign up

Export Citation Format

Share Document